BlackMountain Botanicals, Inc. – Trademark Portfolio
Entity Type: 03
BlackMountain Botanicals, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include OLEVIATE, COGNICAPS, and DR. FOSSUM'S PET CARE. The owner is based in Carefree, AZ.
35133 N. 66th Place
Carefree, AZ 85377
Showing of trademarks Trademarks
Trademark Classifications
BlackMountain Botanicals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does BlackMountain Botanicals, Inc. have?
BlackMountain Botanicals, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does BlackMountain Botanicals, Inc. file in?
BlackMountain Botanicals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BlackMountain Botanicals, Inc.'s most well-known trademarks?
BlackMountain Botanicals, Inc.'s registered trademark portfolio includes well-known marks such as OLEVIATE, COGNICAPS, and DR. FOSSUM'S PET CARE. These are among 3 currently registered trademarks in the portfolio.
What is BlackMountain Botanicals, Inc.'s trademark registration success rate?
BlackMountain Botanicals, Inc. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.